STRENKO Trademark
Trademark Overview
On Wednesday, July 20, 2005, a trademark application was filed for STRENKO with the United States Patent and Trademark Office. The USPTO has given the STRENKO trademark a serial number of 78674036. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, January 22, 2007. This trademark is owned by Bristol-Myers Squibb Company. The STRENKO trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, and pharmaceutical antibody; diagnostic pharmaceutical preparations for human use for increasing the heart rate and contrast imaging agents
General Information
| Serial Number | 78674036 |
| Word Mark | STRENKO |
| Filing Date | Wednesday, July 20, 2005 |
| Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
| Status Date | Monday, January 22, 2007 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, and pharmaceutical antibody; diagnostic pharmaceutical preparations for human use for increasing the heart rate and contrast imaging agents |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, July 26, 2005 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Bristol-Myers Squibb Company |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | New York, NY 10154 |
Trademark Events
| Event Date | Event Description |
| Monday, January 22, 2007 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |
| Monday, January 22, 2007 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Monday, June 26, 2006 | FINAL REFUSAL MAILED |
| Monday, June 26, 2006 | FINAL REFUSAL WRITTEN |
| Tuesday, June 20, 2006 | AMENDMENT FROM APPLICANT ENTERED |
| Friday, May 19, 2006 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, May 19, 2006 | PAPER RECEIVED |
| Friday, November 18, 2005 | NON-FINAL ACTION MAILED |
| Thursday, November 17, 2005 | NON-FINAL ACTION WRITTEN |
| Thursday, November 17, 2005 | ASSIGNED TO EXAMINER |
| Tuesday, July 26, 2005 | NEW APPLICATION ENTERED IN TRAM |
